Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CE.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CE.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CE.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EA.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EA.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.22NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.22NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DH.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DH.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DH.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XGNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XGNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XGNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.9.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.9.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.9.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.6.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.6.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.6.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.34NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.34NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.9.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.9.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.9.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.4.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.4.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.4.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.58NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.58NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.58NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAY.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAY.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAY.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.71NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.71NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.71NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBC.1.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBC.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used